Russia denounced the media's consternation at the killing of Chechnya's rebel chief Aslan Maskhadov as double standards, the Russian foreign ministry told reporters late Friday.
"In word, many urge an active fight against international terrorism, but in deed we are witness to a situation when the destruction of one of the most odious international terrorists prompts regrets," the ministry's spokesman said.
A 53-year-old moderate chief of the Chechen separatists, Maskhadov was reported killed by Russian forces on Tuesday in a village north of Chechnya's capital Grozny.
Russia had charged Maskhadov with involvement in terrorist acts such as the theater crisis in Moscow in 2002, when a group of Chechen commandos took hostage over 800 people, 130 of whom were killed in a resulting siege.
But Maskhadov had always denied any involvement in attacks that targeted civilians and was the only rebel chief who advocated a political solution to the 10-year-old standoff between the separatists and Moscow.
"There are videos that prove that new bloody terrorist acts were being prepared, under Maskhadov's leadership ... and [rebel warlord] Shamil Basayev openly said he acted under Maskhadov's orders," the spokesman said.
Basayev, 40, Russia's most wanted man, has claimed responsibility for some of the most horrific Chechen rebel attacks -- including the school hostage siege in Beslan last year that left more than 340 people, half of them children, dead.
FAKE NEWS? ‘When the government demands the press become a state mouthpiece under the threat of punishment, something has gone very wrong,’ a civic group said The top US broadcast regulator on Saturday threatened media outlets over negative coverage of the Middle East war, after US President Donald Trump slammed critical headlines from the “Fake News Media.” The US president since his first term has derided mainstream media as “fake news” and has sued major outlets over what he sees as unfair coverage. Brendan Carr, head of the US Federal Communications Commission — which oversees the nation’s radio, television and Internet media — said broadcasters risked losing their licenses over news coverage. “The law is clear. Broadcasters must operate in the public interest, and they will
INFLUTENTIAL THEORIST: Habermas was particularly critical of the ‘limited interest’ shown by German politicians in ‘shaping a politically effective Europe Jurgen Habermas, whose work on communication, rationality and sociology made him one of the world’s most influential philosophers and a key intellectual figure in his native Germany, has died. He was 96. Habermas’ publisher, Suhrkamp, said he died on Saturday in Starnberg, near Munich. Habermas frequently weighed in on political matters over several decades. His extensive writing crossed the boundaries of academic and philosophical disciplines, providing a vision of modern society and social interaction. His best-known works included the two-volume Theory of Communicative Action. Habermas, who was 15 at the time of Nazi Germany’s defeat, later recalled the dawn of
The Chinese public maintains relatively warm sentiments toward Taiwan and strongly prefers non-military paths to improving cross-strait relations, a recent survey conducted by the Atlanta, Georgia-based Carter Center and Emory University showed. The “China Pulse” research project, which polled 2,506 adults between Oct. 27 last year and Jan. 1 this year, found that 86 percent of respondents support strengthening cultural ties, while 81 percent favor deepening economic interaction. The report, co-authored by political scientists at Emory University and advisors at the Carter Center, indicates that the Chinese public views Taiwan’s importance through a lens of shared history and culture rather than geopolitical
Cannabis-based medicines have shown little evidence of effectiveness for treating most mental health and substance-use disorders, according to a large review of past studies published in a major medical journal on Monday. Medical use of cannabinoids has been expanding, including in the US, Canada and Australia, where many patients report using cannabis products to manage conditions such as anxiety, post-traumatic stress disorder and sleep problems. Researchers reviewed data from 54 randomized clinical trials conducted between 1980 and May last year involving 2,477 participants for their analysis published in The Lancet. The studies assessed cannabinoids as a primary treatment for mental disorders or substance-use
RSS